Your browser doesn't support javascript.
loading
Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups.
Bolli, Niccolo; Biancon, Giulia; Moarii, Matahi; Gimondi, Silvia; Li, Yilong; de Philippis, Chiara; Maura, Francesco; Sathiaseelan, Vijitha; Tai, Yu-Tzu; Mudie, Laura; O'Meara, Sarah; Raine, Keiran; Teague, Jon W; Butler, Adam P; Carniti, Cristiana; Gerstung, Moritz; Bagratuni, Tina; Kastritis, Efstathios; Dimopoulos, Meletios; Corradini, Paolo; Anderson, Kenneth C; Moreau, Philippe; Minvielle, Stephane; Campbell, Peter J; Papaemmanuil, Elli; Avet-Loiseau, Herve; Munshi, Nikhil C.
Affiliation
  • Bolli N; Department of Oncology and Onco-Hematology, University of Milan, Milan, Italy.
  • Biancon G; Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Moarii M; Cancer Genome Project, Wellcome Trust Sanger Institute, Cambridge, UK.
  • Gimondi S; Department of Oncology and Onco-Hematology, University of Milan, Milan, Italy.
  • Li Y; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • de Philippis C; Department of Oncology and Onco-Hematology, University of Milan, Milan, Italy.
  • Maura F; Cancer Genome Project, Wellcome Trust Sanger Institute, Cambridge, UK.
  • Sathiaseelan V; Department of Oncology and Onco-Hematology, University of Milan, Milan, Italy.
  • Tai YT; Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Mudie L; Department of Oncology and Onco-Hematology, University of Milan, Milan, Italy.
  • O'Meara S; Cancer Genome Project, Wellcome Trust Sanger Institute, Cambridge, UK.
  • Raine K; Harvard Medical School, LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Teague JW; Cancer Genome Project, Wellcome Trust Sanger Institute, Cambridge, UK.
  • Butler AP; Cancer Genome Project, Wellcome Trust Sanger Institute, Cambridge, UK.
  • Carniti C; Cancer Genome Project, Wellcome Trust Sanger Institute, Cambridge, UK.
  • Gerstung M; Cancer Genome Project, Wellcome Trust Sanger Institute, Cambridge, UK.
  • Bagratuni T; Cancer Genome Project, Wellcome Trust Sanger Institute, Cambridge, UK.
  • Kastritis E; Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Dimopoulos M; European Bioinformatics Institute, Computational and Cancer Biology, Cambridge, UK.
  • Corradini P; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
  • Anderson KC; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
  • Moreau P; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
  • Minvielle S; Department of Oncology and Onco-Hematology, University of Milan, Milan, Italy.
  • Campbell PJ; Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Papaemmanuil E; Harvard Medical School, LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Avet-Loiseau H; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
  • Munshi NC; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
Leukemia ; 32(12): 2604-2616, 2018 12.
Article in En | MEDLINE | ID: mdl-29789651
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Multiple Myeloma Type of study: Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2018 Type: Article Affiliation country: Italy
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Multiple Myeloma Type of study: Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2018 Type: Article Affiliation country: Italy